Result of AGM

/**/

RNS Number : 2017N Bradda Head Lithium Ltd 30 December 2025  

     





30 December 2025   Bradda Head Lithium Ltd ("Bradda Head", "BHL" or the "Company")   Results of Annual General Meeting Bradda Head Lithium Ltd (AIM:BHL), the North America-focused lithium development group, announces that at the Annual General Meeting ("AGM") held earlier today, all resolutions were passed.     For further information:   

Bradda Head Lithium Limited

  Beaumont Cornish  

Shard Capital

  Tavistock  

Company

Nomad

Broker

Investor Relations

Ian Stalker, Executive Chair Denham Eke, Finance Director

James Biddle / Roland Cornish

Damon Heath / Isabella Pierre

Nick Elwes / Josephine Clerkin 

+44 1624 639 396

+44 20 7628 3396

+44 207 186 9927

+ 44 20 7920 3150 braddahead@tavistock.co.uk

      About Bradda Head Lithium Ltd. Bradda Head Lithium Ltd. is a North America-focused lithium development group. The Company currently has interests in a variety of projects, the most advanced of which are in Central and Western Arizona: The Basin Project (Basin East Project and Basin West Project) and the San Domingo Project.   The Basin East Project has a Measured Mineral Resource of 20 Mt at an average grade of 929 ppm Li for a total of 99 kt LCE and an Indicated Mineral Resource of 122 Mt at an average grade of 860 ppm Li and an Inferred Mineral Resource of 499 Mt at an average grade of 810 ppm Li for a total of 2.81 Mt LCE. The Group intends to continue to develop its three phase one projects in Arizona, whilst endeavouring to unlock value at its other prospective pegmatite and brine assets in Arizona, Nevada, and Pennsylvania. All of Bradda Head's licences are held on a 100% equity basis and are in close proximity to the required infrastructure. Bradda Head is quoted on the AIM of the London Stock Exchange with the ticker of BHL.    END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.  END  RAGPKKBKFBDDQBN